Tirzepatide, a novel medication, is creating considerable buzz within the scientific community. It functions differently from traditional diabetes treatments , targeting both receptors involved in blood regulation and satiety. Initial research have demonstrated impressive efficacy in reducing blood sugar in individuals with type 2 diabetes and, imp